InChI=1S/C44H82NO8P/c1-6-8-10-12-14-16-18-20-21-22-23-25-27-29-31-33-35-37-44(47)53-42(41-52-54(48,49)51-39-38-45(3,4)5)40-50-43(46)36-34-32-30-28-26-24-19-17-15-13-11-9-7-2/h20-21,23,25,29,31,42H,6-19,22,24,26-28,30,32-41H2,1-5H3/b21-20-,25-23-,31-29-/t42-/m1/s1 |
XMZFUVYOYPLVOA-VLHUWQDUSA-N |
[C@@H](COC(CCCCCCCCCCCCCCC)=O)(COP(OCC[N+](C)(C)C)(=O)[O-])OC(CCC/C=C\C/C=C\C/C=C\CCCCCCCC)=O |
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via phosphatidylcholine 36:3 )
|
|
View more via ChEBI Ontology
Outgoing
|
1-hexadecanoyl-2-[(5Z,8Z,11Z)-icosatrienoyl]-sn-glycero-3-phosphocholine
(CHEBI:86119)
has functional parent
(5Z,8Z,11Z)-icosatrienoic acid
(CHEBI:72865)
1-hexadecanoyl-2-[(5Z,8Z,11Z)-icosatrienoyl]-sn-glycero-3-phosphocholine
(CHEBI:86119)
has functional parent
hexadecanoic acid
(CHEBI:15756)
1-hexadecanoyl-2-[(5Z,8Z,11Z)-icosatrienoyl]-sn-glycero-3-phosphocholine
(CHEBI:86119)
is a
1-palmitoyl-2-icosatrienoyl-sn-glycero-3-phosphocholine
(CHEBI:133631)
|
|
(2R)-3-(hexadecanoyloxy)-2-{[(5Z,8Z,11Z)-icosa-5,8,11-trienoyl]oxy}propyl 2-(trimethylazaniumyl)ethyl phosphate
|
1-hexadecanoyl-2-(5Z,8Z,11Z-eicosatrienoyl)-sn-glycero-3-phosphocholine
|
UniProt
|
1-hexadecanoyl-2-[(5Z,8Z,11Z)-eicosatrienoyl]-sn-glycero-3-phosphocholine
|
ChEBI
|
1-palmitoyl-2-meadoyl-GPC
|
ChEBI
|
1-palmitoyl-2-meadoyl-GPC (16:0/20:3n9)
|
ChEBI
|
1-Palmitoyl-2-meadoyl-sn-glycero-3-phosphocholine
|
HMDB
|
GPC(16:0/20:3n9)
|
ChEBI
|
GPCho(16:0/20:3)
|
HMDB
|
GPCho(16:0/20:3n9)
|
HMDB
|
GPCho(16:0/20:3w9)
|
HMDB
|
PC(16:0/20:3(5Z,8Z,11Z))
|
LIPID MAPS
|
PC(16:0/20:3)
|
HMDB
|
PC(16:0/20:3n9)
|
HMDB
|
PC(16:0/20:3w9)
|
HMDB
|
PC(36:3)
|
HMDB
|
Phosphatidylcholine(16:0/20:3)
|
HMDB
|
Phosphatidylcholine(16:0/20:3n9)
|
HMDB
|
Phosphatidylcholine(16:0/20:3w9)
|
HMDB
|
Phosphatidylcholine(36:3)
|
HMDB
|
24023812
|
PubMed citation
|
Europe PMC
|
|